|
Market Closed -
Canadian Securities Exchange
14:28:13 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.0250 CAD | +25.00% |
|
+25.00% | - |
| Market Cap | 184K 165K 152K 137K 257K 17.48M 262K 1.81M 726K 9.2M 691K 676K 29M | P/E 2024 |
1.22x | P/E 2025 | -2.21x |
|---|---|---|---|---|---|
| Enterprise Value | 246K 220K 202K 183K 343K 23.32M 349K 2.41M 969K 12.27M 922K 902K 38.69M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
67.71% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| NSHS.X | Delayed | |
OTC Markets
| NSHS.F | Delayed | |
|
Deutsche Boerse AG
| 2CG | Delayed | |
|
Börse Stuttgart
| 2CG | Delayed |
| 1 day | +25.00% | ||
| 1 week | +25.00% | ||
| Current month | +25.00% | ||
| 1 month | +25.00% | ||
| 3 months | +25.00% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.02 |
| Current year | 0.02 | | 0.03 |
| 1 year | 0.02 | | 0.04 |
| 3 years | 0 | | 0.18 |
| 5 years | 0 | | 0.29 |
| 10 years | 0 | | 23.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Kaufman
CTO | Chief Tech/Sci/R&D Officer | - | 2012-12-31 |
Bennett Liu
DFI | Director of Finance/CFO | 33 | 2017-10-31 |
Toby Lim
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Iverson
CHM | Chairman | 74 | 2019-07-09 |
Toby Lim
BRD | Director/Board Member | - | 2017-11-16 |
Richard Kaufman
BRD | Director/Board Member | - | 2017-11-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/17/21 | Other | Director | 0 | 0% | ||
| 9/17/21 | Other | Director | 0 | 0% | ||
| 9/17/21 | Sell | Chairman | 338,956 | 6.2564% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +25.00% | +25.00% | -16.67% | +66.67% | 147K | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +4.06% | +5.05% | +40.26% | +81.49% | 417.68B | |
| Weighted average by Cap. | +1.17% | +6.35% | +50.91% | +98.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 263K 236K 217K 197K 367K 25M 374K 2.59M 1.04M 13.15M 988K 967K 41.48M | -84.78K -75.93K -69.84K -63.28K -118K -8.05M -121K -833K -334K -4.23M -318K -311K -13.35M |
| Net Debt | 28.69K 25.69K 23.63K 21.41K 40.03K 2.72M 40.78K 282K 113K 1.43M 108K 105K 4.52M | 61.51K 55.09K 50.67K 45.92K 85.83K 5.84M 87.43K 604K 243K 3.07M 231K 226K 9.69M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | $0.0250 | +25.00% | 8,000 |
- Stock Market
- Stocks
- NSHS.X Stock
Select your edition
All financial news and data tailored to specific country editions
